Company Encyclopedia
View More
name
Steris
STE.US
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services.
1.407 T
STE.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
Health Care EquipmentIndustry
Industry Ranking10/171
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE10.14%B
    • Profit Margin12.07%B
    • Gross Margin44.16%B
  • Growth ScoreB
    • Revenue YoY7.08%C
    • Net Profit YoY58.35%B
    • Total Assets YoY1.65%C
    • Net Assets YoY6.23%B
  • Cash ScoreB
    • Cash Flow Margin828.31%B
    • OCF YoY7.08%C
  • Operating ScoreC
    • Turnover0.55C
  • Debt ScoreB
    • Gearing Ratio32.54%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Steris PLC Stock Underperforms Tuesday When Compared To Competitors

    Steris PLC's stock fell 1.37% to $259.30 on Tuesday, marking its fourth consecutive day of losses. Despite a positive trading session for the market, Steris underperformed compared to competitors like Danaher Corp., which rose 1.09%. The stock closed 3.46% below its 52-week high, with trading volume below its 50-day average.

    Dow Jones·
    US
    DHR
    -0.58%
    US
    STE
    +0.62%
    Dow Jones·
    US
    DHR
    -0.58%
    US
    STE
    +0.62%

    Steris PLC Stock Underperforms Monday When Compared To Competitors

    Steris PLC's stock fell 1.27% to $262.89 on Monday, underperforming compared to competitors like Thermo Fisher, Danaher, and Becton Dickinson. This marks the third consecutive day of losses for Steris, closing 2.13% below its 52-week high. Trading volume exceeded its 50-day average.

    Dow Jones·
    US
    STE
    +0.62%
    Dow Jones·
    US
    STE
    +0.62%

    STERIS plc $STE Shares Acquired by Neuberger Berman Group LLC

    Neuberger Berman Group LLC increased its stake in STERIS plc by 64.7% in Q2, owning 19,416 shares worth $4.664 million. Analysts have given STERIS a "Moderate Buy" rating with a consensus price target of $273.50. The stock opened at $266.28, with a market cap of $26.13 billion. STERIS reported Q3 earnings of $2.47 per share, beating estimates. The company announced a quarterly dividend of $0.63, payable on December 18th.

    Market Beat·
    US
    STE
    +0.62%
    Market Beat·
    US
    STE
    +0.62%

    Cardinal Health Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

    Cardinal Health Inc. stock rose 1.20% to $213.73 on Tuesday, marking its seventh consecutive day of gains and hitting a new 52-week high. Despite this, it underperformed compared to competitors like Amazon, UnitedHealth Group, and CVS Health, which saw higher percentage increases. The S&P 500 and Dow Jones also experienced gains.

    Dow Jones·
    US
    CAH
    -0.26%
    Dow Jones·
    US
    CAH
    -0.26%

    Steris Insider Sold Shares Worth $1,312,096, According to a Recent SEC Filing

    04:44 PM EST, 11/25/2025 (MT Newswires) -- Julia Madsen, Senior Vice President and General Manager, Life Sciences, on November 21, 2025, sold 5,008 shares in Steris ( STE ) for $1,312,096. Following the Form 4 filing with the SEC, Madsen has control over a total of 10,710 ordinary shares of the company, with 10,710 shares held directly.SEC Filing: MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

    fidelity·
    US
    STE
    +0.62%
    fidelity·
    US
    STE
    +0.62%
    Posts
    View More

    Keep an eye on this one ✍️

    Rep. April Delaney just bought ~$30K buy of STERIS.

    $Steris(STE.US) makes sterilization and surgical products for the US healthcare system

    It’s subsidiary works with NASA on sp.........
    • 0
    © 2025 Longbridge｜Disclaimer